Literature DB >> 24333536

Semaphorin 7A is expressed on airway eosinophils and upregulated by IL-5 family cytokines.

Stephane Esnault1, Elizabeth A Kelly2, Mats W Johansson3, Lin Ying Liu2, Shih-Tsung Han3, Moneeb Akhtar2, Nathan Sandbo2, Deane F Mosher3, Loren C Denlinger2, Sameer K Mathur2, James S Malter4, Nizar N Jarjour2.   

Abstract

Semaphorin 7A (sema7a) plays a major role in TGF-β1-induced lung fibrosis. Based on the accumulating evidence that eosinophils contribute to fibrosis/remodeling in the airway, we hypothesized that airway eosinophils may be a significant source of sema7a. In vivo, sema7a was expressed on the surface of circulating eosinophils and upregulated on bronchoalveolar lavage eosinophils obtained after segmental bronchoprovocation with allergen. Based on mRNA levels in unfractionated and isolated bronchoalveolar cells, eosinophils are the predominant source of sema7a. In vitro, among the members of the IL-5-family cytokines, sema7a protein on the surface of blood eosinophils was increased more by IL-3 than by GM-CSF or IL-5. Cytokine-induced expression of cell surface sema7a required translation of newly synthesized protein. Finally, a recombinant sema7a induced alpha-smooth muscle actin production in human bronchial fibroblasts. semaphorin 7A is a potentially important modulator of eosinophil profibrotic functions in the airway remodeling of patients with chronic asthma.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BAL; EOS; Eosinophil; Fibrosis; IL-3; RT-qPCR; SBP-Ag; Sema7a; Semaphorin 7A; Translation; bronchoalveolar lavage; eosinophils; real-time quantitative PCR; segmental bronchoprovocation with allergen; semaphorin 7A.

Mesh:

Substances:

Year:  2013        PMID: 24333536      PMCID: PMC3947215          DOI: 10.1016/j.clim.2013.11.009

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  38 in total

1.  A critical role for eosinophils in allergic airways remodeling.

Authors:  Alison A Humbles; Clare M Lloyd; Sarah J McMillan; Daniel S Friend; Georgina Xanthou; Erin E McKenna; Sorina Ghiran; Norma P Gerard; Channing Yu; Stuart H Orkin; Craig Gerard
Journal:  Science       Date:  2004-09-17       Impact factor: 47.728

2.  Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution.

Authors:  S I Rennard; G Basset; D Lecossier; K M O'Donnell; P Pinkston; P G Martin; R G Crystal
Journal:  J Appl Physiol (1985)       Date:  1986-02

3.  Semaphorin 7A contributes to TGF-β-mediated liver fibrogenesis.

Authors:  Samuele De Minicis; Chiara Rychlicki; Laura Agostinelli; Stefania Saccomanno; Luciano Trozzi; Cinzia Candelaresi; Ramon Bataller; Cristina Millán; David A Brenner; Marco Vivarelli; Federico Mocchegiani; Marco Marzioni; Antonio Benedetti; Gianluca Svegliati-Baroni
Journal:  Am J Pathol       Date:  2013-07-11       Impact factor: 4.307

4.  Comparison of airway and blood eosinophil function after in vivo antigen challenge.

Authors:  J B Sedgwick; W J Calhoun; R F Vrtis; M E Bates; P K McAllister; W W Busse
Journal:  J Immunol       Date:  1992-12-01       Impact factor: 5.422

5.  Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma.

Authors:  D S Robinson; S Ying; A M Bentley; Q Meng; J North; S R Durham; A B Kay; Q Hamid
Journal:  J Allergy Clin Immunol       Date:  1993-09       Impact factor: 10.793

6.  Ets-1 regulates TNF-alpha-induced matrix metalloproteinase-9 and tenascin expression in primary bronchial fibroblasts.

Authors:  Yutaka Nakamura; Stéphane Esnault; Takashi Maeda; Elizabeth A B Kelly; James S Malter; Nizar N Jarjour
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

7.  Decreased expression of membrane IL-5 receptor alpha on human eosinophils: I. Loss of membrane IL-5 receptor alpha on airway eosinophils and increased soluble IL-5 receptor alpha in the airway after allergen challenge.

Authors:  Lin Ying Liu; Julie B Sedgwick; Mary Ellen Bates; Rose F Vrtis; James E Gern; Hirohita Kita; Nizar N Jarjour; William W Busse; Elizabeth A B Kelly
Journal:  J Immunol       Date:  2002-12-01       Impact factor: 5.422

8.  Defining a link with asthma in mice congenitally deficient in eosinophils.

Authors:  James J Lee; Dawn Dimina; MiMi P Macias; Sergei I Ochkur; Michael P McGarry; Katie R O'Neill; Cheryl Protheroe; Ralph Pero; Thanh Nguyen; Stephania A Cormier; Elizabeth Lenkiewicz; Dana Colbert; Lisa Rinaldi; Steven J Ackerman; Charles G Irvin; Nancy A Lee
Journal:  Science       Date:  2004-09-17       Impact factor: 47.728

9.  Differential regulation of human eosinophil IL-3, IL-5, and GM-CSF receptor alpha-chain expression by cytokines: IL-3, IL-5, and GM-CSF down-regulate IL-5 receptor alpha expression with loss of IL-5 responsiveness, but up-regulate IL-3 receptor alpha expression.

Authors:  Bernard Gregory; Antje Kirchem; Simon Phipps; Phillipe Gevaert; Carol Pridgeon; Sara M Rankin; Douglas S Robinson
Journal:  J Immunol       Date:  2003-06-01       Impact factor: 5.422

10.  Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics.

Authors:  Patrick Flood-Page; Andrew Menzies-Gow; Simon Phipps; Sun Ying; Arun Wangoo; Mara S Ludwig; Neil Barnes; Douglas Robinson; A Barry Kay
Journal:  J Clin Invest       Date:  2003-10       Impact factor: 14.808

View more
  23 in total

1.  IL-3 Maintains Activation of the p90S6K/RPS6 Pathway and Increases Translation in Human Eosinophils.

Authors:  Stephane Esnault; Elizabeth A B Kelly; Zhong-Jian Shen; Mats W Johansson; James S Malter; Nizar N Jarjour
Journal:  J Immunol       Date:  2015-08-14       Impact factor: 5.422

2.  Proteomic and Phosphoproteomic Changes Induced by Prolonged Activation of Human Eosinophils with IL-3.

Authors:  Stephane Esnault; Alexander S Hebert; Nizar N Jarjour; Joshua J Coon; Deane F Mosher
Journal:  J Proteome Res       Date:  2018-05-04       Impact factor: 4.466

3.  Human Eosinophils Express a Distinct Gene Expression Program in Response to IL-3 Compared with Common β-Chain Cytokines IL-5 and GM-CSF.

Authors:  Ryan K Nelson; Howard Brickner; Bharat Panwar; Ciro Ramírez-Suástegui; Sara Herrera-de la Mata; Neiman Liu; Damaris Diaz; Laura E Crotty Alexander; Ferhat Ay; Pandurangan Vijayanand; Grégory Seumois; Praveen Akuthota
Journal:  J Immunol       Date:  2019-06-07       Impact factor: 5.422

Review 4.  Activation states of blood eosinophils in asthma.

Authors:  M W Johansson
Journal:  Clin Exp Allergy       Date:  2014-04       Impact factor: 5.018

Review 5.  Neuroimmune semaphorins as costimulatory molecules and beyond.

Authors:  Svetlana P Chapoval
Journal:  Mol Med       Date:  2018-04-04       Impact factor: 6.354

6.  IL-3 up-regulates and activates human eosinophil CD32 and αMβ2 integrin causing degranulation.

Authors:  S Esnault; M W Johansson; E A Kelly; L Koenderman; D F Mosher; N N Jarjour
Journal:  Clin Exp Allergy       Date:  2017-01-23       Impact factor: 5.018

Review 7.  Essential Mechanisms of Differential Activation of Eosinophils by IL-3 Compared to GM-CSF and IL-5.

Authors:  Stephane Esnault; Elizabeth A Kelly
Journal:  Crit Rev Immunol       Date:  2016       Impact factor: 2.214

8.  Semaphorin 7A modulates cytokine-induced memory-like responses by human natural killer cells.

Authors:  Joshua Ghofrani; Olivier Lucar; Haley Dugan; R Keith Reeves; Stephanie Jost
Journal:  Eur J Immunol       Date:  2019-05-02       Impact factor: 5.532

9.  Mepolizumab Attenuates Airway Eosinophil Numbers, but Not Their Functional Phenotype, in Asthma.

Authors:  Elizabeth A Kelly; Stephane Esnault; Lin Ying Liu; Michael D Evans; Mats W Johansson; Sameer Mathur; Deane F Mosher; Loren C Denlinger; Nizar N Jarjour
Journal:  Am J Respir Crit Care Med       Date:  2017-12-01       Impact factor: 21.405

Review 10.  Functions of tissue-resident eosinophils.

Authors:  Peter F Weller; Lisa A Spencer
Journal:  Nat Rev Immunol       Date:  2017-09-11       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.